Literature DB >> 12791828

Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.

Annette Altmann1, Maria Kissel, Sabine Zitzmann, Wolfgang Kübler, Miriam Mahmut, Peter Peschke, Uwe Haberkorn.   

Abstract

UNLABELLED: The transport of MIBG by the human norepinephrine transporter (hNET) seems to be the critical step in the treatment of MIBG-concentrating tumors. Therefore, we investigated whether the accumulation of MIBG may be induced by retroviral transfection of the hNET gene in Morris hepatoma cells.
METHODS: A bicistronic retroviral vector for the transfer of the hNET coding sequence and the hygromycin resistance gene was generated. Morris hepatoma cells (MH3924A) were infected with the respective retroviral particles, and hNET-expressing cell lines MHhNEThyg1 to MHhNEThyg9 were obtained through hygromycin selection. The uptake of (3)H-norepinephrine or (131)I-MIBG and the efflux of (131)I-MIBG were determined in transfected and wild-type cells. In addition, the (131)I-MIBG distribution was monitored in nude mice and rats bearing wild-type and hNET-expressing hepatomas.
RESULTS: hNET-expressing hepatoma cell lines accumulated up to 36 times more norepinephrine than did wild-type cells and 8 times more than did hNET-expressing neuroblastoma cell line SK-N-SH. The addition of nisoxetine, a selective inhibitor of noradrenaline uptake, inhibited norepinephrine uptake. Maximal (131)I-MIBG accumulation was observed 2 h after incubation and was followed by 43% efflux within 4 h after the (131)I-MIBG-containing medium had been removed. In vivo experiments performed with nude mice bearing both hNET-expressing and wild-type tumors showed a 10-fold-higher accumulation of (131)I-MIBG in transfected tumors than in wild-type tumors. The ex vivo calculations revealed doses of 605 and 75 mGy in hNET-expressing and wild-type tumor tissues, respectively.
CONCLUSION: Transduction of the hNET gene enables Morris hepatoma cells to accumulate norepinephrine and MIBG. However, the retention of MIBG is brief; therefore, the absorbed dose of radiation in vivo is not expected to be therapeutically effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791828

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

Review 1.  Gene expression and gene therapy imaging.

Authors:  Claire Rome; Franck Couillaud; Chrit T W Moonen
Journal:  Eur Radiol       Date:  2006-09-12       Impact factor: 5.315

2.  Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.

Authors:  Yanlin Zhao; Xiao Zhong; Xiaohong Ou; Huawei Cai; Xiaoai Wu; Rui Huang
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 3.  In vivo molecular and single cell imaging.

Authors:  Seongje Hong; Siyeon Rhee; Kyung Oh Jung
Journal:  BMB Rep       Date:  2022-06       Impact factor: 5.041

Review 4.  Norepinephrine Transporter as a Target for Imaging and Therapy.

Authors:  Neeta Pandit-Taskar; Shakeel Modak
Journal:  J Nucl Med       Date:  2017-09       Impact factor: 10.057

Review 5.  Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.

Authors:  Steven G DuBois; Katherine K Matthay
Journal:  Nucl Med Biol       Date:  2008-08       Impact factor: 2.408

Review 6.  Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas.

Authors:  G Eisenhofer; G Siegert; J Kotzerke; S R Bornstein; K Pacak
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

7.  Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[18F]Fluorobenzylguanidine: Biodistribution and Radiation Dosimetry.

Authors:  Stephen J Lokitz; Sudha Garg; Rachid Nazih; Pradeep K Garg
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

8.  Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging.

Authors:  Vania Kenanova; Bhaswati Barat; Tove Olafsen; Arion Chatziioannou; Harvey R Herschman; Jonathan Braun; Anna M Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-22       Impact factor: 9.236

9.  Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.

Authors:  Steven G Dubois; Ethan Geier; Vandana Batra; Sook Wah Yee; John Neuhaus; Mark Segal; Daniel Martinez; Bruce Pawel; Greg Yanik; Arlene Naranjo; Wendy B London; Susan Kreissman; David Baker; Edward Attiyeh; Michael D Hogarty; John M Maris; Kathleen Giacomini; Katherine K Matthay
Journal:  Int J Mol Imaging       Date:  2012-09-25

Review 10.  The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies.

Authors:  Alan R Penheiter; Stephen J Russell; Stephanie K Carlson
Journal:  Curr Gene Ther       Date:  2012-02-01       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.